You have 9 free searches left this month | for more free features.

Overall Status

Active, not recruiting (1)

Recruiting (1)

Terminated (1)

Sign in for free

Phase

early phase 1 (1)

phase 1 (1)

phase 3 (1)

Sponsor

Actinium Pharmaceuticals (1)

Fred Hutchinson Cancer Center (1)

Memorial Sloan Kettering Cancer Center (1)

Collaborator

Actinium Pharmaceuticals (1)

National Cancer Institute (NCI) (1)

Study Documents

Intervention Type

drug (3)

procedure (2)

biological (1)

other (1)

radiation (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

Iomab

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

B-ALL, DLBCL, B ALL Trial in New York (131-I Apamistamab, CAR T-cell)

Recruiting

B-ALL
+10 more

131-I Apamistamab
CAR T-cell

New York, New York

Memorial Sloan Kettering Cancer Center

Mar 7, 2022

Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

Active, not recruiting

Acute Myeloid Leukemia
+8 more

Iomab-B
+2 more

Gilbert, Arizona
+23 more

Feb 22, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult

Terminated

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
+9 more

Allogeneic Bone Marrow Transplantation
+7 more

Seattle, Washington

Fred Hutch/University of Washington Cancer Consortium

Oct 4, 2021